Amonsot, Maria L.

HRN: 28-71-30  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/20/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/20/2026
03/27/2026
IV
600mg
Q6H
Cellulitis
Remove - Pending Acceptance
03/20/2026
CIPROFLOXACIN 500MG (TAB)
03/20/2026
03/27/2026
PO
500
BID
Cellulitis
Remove - Pending Acceptance
03/23/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/23/2026
03/30/2026
IVTT
1.5g
Q6H
CELLULITIS
Remove - Pending Acceptance
03/28/2026
CLINDAMYCIN 300MG (CAP)
03/28/2026
04/03/2026
PO
300mg
Q8
Cellulits
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: